Uveitis Treatment Market: Global Industry Analysis, Trend, Development, Segmentation, Forecasts to 2031

 Uveitis Treatment Market 2022

The US$ 497 Mn uveitis treatment market is likely to expand at a stable CAGR of 6.5% over the next eight years. In 2017, the market is expected to witness nearly 6.7% Y-o-Y growth over 2016. During 2016-2024, Persistence Market Research predicts a positive growth outlook for the global uveitis treatment market, influenced by several growth drivers, restraints, trends, and opportunities.

In its recently published report titled “Uveitis Treatment Market: Industry Analysis and Forecast, 2016–2024,” the company provides in-depth analysis of the market growth prospects for the eight-year assessment period, backing it up with historic and current market data.

Want Insights To Uveitis Market? Ask For Sample! https://www.persistencemarketresearch.com/samples/3596

Company Profiles

• Allergan, Inc.,
• Bausch & Lomb Incorporated.
• Novartis AG (Alcon Laboratories Inc.)
• AbbVie Inc.
• Santen Pharmaceutical Co., Ltd
• Eyegate Pharmaceuticals, Inc.
• Alimera Sciences, Inc.
• pSivida Corp.

Planning To Conclude Your Strategy On A Decisive Note In The Uveitis Market? Glance Through The “Methodology” Implied! https://www.persistencemarketresearch.com/methodology/3596

Persistence Market Research identified a few important drivers and trends that will continue to present attractive growth opportunities during 2016-2024.

While surge in autoimmune disorders is identified to primarily generate the demand for uveitis, the market has been witnessing strong emergence of immunosuppressive therapies to treat uveitis since the past few years, which is expected to create a new set of opportunities for leading players in near future.

“Some of the leading companies in the uveitis treatment marketplace have been investing in new, improved product launches since the past decade. While a significant number of uveitis drugs are already in the pipeline, increasing in-licensing approvals for new market entrants will boost the scope of treatment against uveitis, ultimately creating new lucrative opportunities,” states Persistence Market Research.

• Increasing demand for generic drugs also prompt at an important trend in the global uveitis treatment market that will reportedly generate a range of opportunities for established as well as new pharma players.
• In addition to growing R&D activities in the field of eye disorders, rising optometric clinical practice will also provide an impetus to market growth.
• With surging uveitis prevalence, a host of biological drug development projects is anticipated to push the potential of the uveitis treatment market.
• Moreover, growing prevalence of TB associated with intermediate uveitis will continue to push the opportunities in intermediate uveitis segment.
• Another proliferating trend in uveitis treatment market includes increasing demand for local steroid implants, especially for non-infectious posterior uveitis.
• As corticosteroid mono-therapy is no more considered the first line treatment for uveitis, the market has been witnessing introduction of various modified corticosteroid medication and drug delivery methods since the recent past.
• Major players in the segment are working to add novel drugs to their product portfolio.
• R&D in topical agents segment will also benefit the market growth in near future.

How About Knowing The Product/Technology Driving The Uveitis Market Before Investing Therein? Click The “Purchase Now” Button Of Our Uveitis Market Report! https://www.persistencemarketresearch.com/checkout/3596

Segmentation by treatment type:

• Corticosteroids
• Immunosuppressants
• Monoclonal antibodies
• Cycloplegic agents
• Antibodies
• Antivirals
• Antifungals
• Analgesics

Corticosteroids will remain the largest segment, followed by antibiotics and monoclonal antibodies. While corticosteroids segment is foreseen to account for a dominant market share of over 21% in 2024, antibiotics segment is expected to witness the fastest growth at a CAGR of 8% – reaching beyond US$ 146 Mn over 2016-2024. Monoclonal antibodies segment will also exhibit healthy growth at a CAGR of 7%, reaching revenues worth US$ 142.7 Mn by the end of 2024.

Segmentation by disease type:

• Anterior uveitis
• Posterior uveitis
• Intermediate uveitis
• Panuveitis

Anterior uveitis segment will continue to dominate. Through 2024, this segment will capture around 60% value share, representing a value of over US$ 500 Mn. Posterior uveitis is also estimated for a considerable market value share of over 23% in 2024. Attributed to increased prevalence of TB in intermediate uveitis, the intermediate uveitis will possibly be the second fastest growing segment over the forecast period.

Segmentation by cause:

• Infectious
• Non-infectious

On the basis of cause, infectious uveitis will remain the larger segment with over 87% share by 2024 end but non-infectious uveitis is predicted to witness a higher CAGR of 7.4% during the eight-year period.

Segmentation by distribution channel:

• Hospital pharmacies
• Retail pharmacies
• Online pharmacies
• Drug stores

By distribution channel, hospital pharmacies segment will account for over 46% revenue share in 2024, whereas retail pharmacies segment is likely to capture around 30% share. Online pharmacies and drug stores segments will also witness healthy growth at over 6% CAGR during the aforementioned period.

Segmentation by region:

The report provides regional analysis that examines the global market classifying it into five key regions.

• North America
• Latin America
• Europe
• Asia Pacific (APAC)
• Middle East and Africa (MEA)

North America, the largest and fastest growing regional market for uveitis treatment globally, will retain its dominant position over the assessed period. With over 34% market value share in 2024, this regional will possibly account for around US$ 290 Mn. Europe will remain the second key market with nearly 27% share by the end of forecast period, followed by Asia Pacific.

About Us :-

Persistence Market Research is here to provide companies a one-stop solution with regards to bettering customer experience. It does engage in gathering appropriate feedback after getting through personalized customer interactions for adding value to customers’ experience by acting as the “missing” link between “customer relationships” and “business outcomes’. The best possible returns are assured therein.

Contact us:

Persistence Market Research
Address – 305 Broadway, 7th FloorNew York City,
NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – sales@persistencemarketresearch.com

 

Advanced Computed Tomography Scanners Market: Global Industry Share, Future Growth, Trends, Size and Forecast to 2031

 Advanced Computed Tomography Scanners Market 2022

Understanding various facets of the advanced computed tomography scanners market, Persistence Market Research has come up with an analytical research report titled “Advanced Computed Tomography Scanners Market: Global Industry Analysis (2012-2016) and Forecast (2017-2027)”.

This comprehensive research report focuses on various trends, developments, drivers, opportunities and restraints that influence the growth of the global advanced CT scanners market. The intensity of these aspects vary across various geographies. The scenario of these factors is covered in this study which gives a heads up to the reader from an investment standpoint. Along with historical data, the study covers a weighted forecast analysis for a period of 10 years, starting from 2017 till 2027.

How About Looking Through The Sample Of Advanced Computed Tomography Scanners Market Report? https://www.persistencemarketresearch.com/samples/2234

Company Profiles

Koninklijke Philips N.V.
General Electric Company
Siemens AG
Carestream Health, Inc.
Canon Inc.
Xoran Technologies, LLC.
Medtronic, Plc.
iCRco, Inc.
NeuroLogica Corp.

How About Step-By-Step Insights To Advanced Computed Tomography Scanners Market? Look Through The “Methodology” Employed! https://www.persistencemarketresearch.com/methodology/22348

Global Market for Advanced CT Scanners: Segmental Snapshot

The global market for advanced CT scanners is segmented on the basis of product type, end user and region.

By product type, the adoption of cone beam CT scanners is expected to soar at a high rate in the coming years, making it a fast growing segment. Low dose CT scanners segment is the largest with maximum value share

By region, North America is the most lucrative and is expected to dominate the global market with a high market share. By the end of the year of assessment, the advanced CT scanners market in North America is projected to expand at a stellar CAGR and is estimated to reach a billion dollar milestone

By end user, hospitals and diagnostic centers expected to largely contribute to the growth of the global market for advanced CT scanners

Increasing Strategic Collaborations Between Players to Present Lucrative Growth Opportunities in the Global Market

Strategic collaborations among key players in the advanced CT scanners market is expected to present potential growth opportunities for advanced CT scanners. Strategic alliances and collaborations can spur the development rate of the market as key players can focus on the development of innovative technologies and advanced imaging systems. Collaborations are usually carried out by players that have a strong product portfolios and patented technologies.

This can support the international players in gaining market hold with the support of local players in that respective region. For instance, Toshiba Medical Systems signed contracts with Russian imaging equipment manufacturer ZAO Roentgenprom to carry out licensing and sub-contracting production of CT scanners in the country.

Want To Keep A Tab On The Latest Findings In The Advanced Computed Tomography Scanners Market? Purchase Our Advanced Computed Tomography Scanners Market Report Now! https://www.persistencemarketresearch.com/checkout/22348

This initiative was a move towards enhancement of the healthcare system and infrastructure in Russia with main goal being the improvement in the country’s overall healthcare space.

Moreover, increasing number of diagnostic centers is anticipated to spur the demand for advanced CT scanners. Since recent past, a number of diagnostics and imaging centers across various emerging and developed regions has increased substantially. Independent diagnostic centers offer better service and superior quality diagnosis at a pocket friendly cost.

Several insurance companies have adopted efficient marketing strategies to shift the patient volume to the cost efficient independent diagnostic centers thus reducing the out of pocket costs of the patients.

Global Market for Advanced CT Scanners: Factors Influencing Growth

There are several aspects that have contributed to the growth of the global advanced computed tomography scanners market.

Aspects such as increasing ageing population, growing need for medical imaging across various regions in the globe, increasing prevalence and growth in adoption of minimally invasive diagnostic procedures, high funding for research and development to carry out product innovations in medical devices and imaging systems, ease in FDA clearance, increasing prevalence of chronic diseases such as cancer, cardiovascular diseases, and dental and orthopedic disorders, growing number of hospitals and diagnostic centers and growing need for faster and more definitive result are driving the growth of the global market.

However, factors such as exposure to radiation, inadequate reimbursement policies, adoption of refurbished medical devices, lack of skilled personnel and lack of healthcare infrastructure in emerging markets are the main challenges restricting the growth of the global market for advanced CT scanners.

About Us: Persistence Market Research

Contact Us:

Persistence Market Research
Address – 305 Broadway, 7th Floor, New York City, NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – sales@persistencemarketresearch.com

 

Host Cell Contaminant Testing Market by Component, Application, Growth and Analysis – 2031

 Host Cell Contaminant Testing Market 2022

Persistence Market Research (PMR) has recently published a report titled “Host Cell Contaminant Testing Market: Global Industry Analysis (2012 – 2016) and Forecast (2017 – 2025).” The report states that the healthcare industry is transforming at a rapid pace and is venturing into different possibilities for research and development of new technologies.

Several government and regulatory bodies of various countries are adopting various cost containment measures to reduce healthcare burden, especially in developed economies. This shift from volume- to value based system is driven by various measures taken by governments, providers, payers and life sciences companies, which include outcome-based pricing, profit and risk sharing, price control and competitive tendering.

Get Going With Sample Of Host Cell Contaminant Testing Market Report! https://www.persistencemarketresearch.com/samples/21355

Company Profiles

• BioGenes GmbH
• Bio-Rad Laboratories, Inc.
• Cisbio Bioassays
• Cygnus Technologies LLC (A Maravai Lifesciences Company)
• Enzo Life Sciences, Inc.
• ForteBio (A Pall Company)
• GE Healthcare Life Sciences
• Molecular Devices LLC
• ProteinSimple (A BioTechne Brand)
• Thermo Fisher Scientific, Inc.

How About Re-Inventing The Methodical Wheel In The Host Cell Contaminant Testing Market? Switch Over To The “Methodology” Tab! https://www.persistencemarketresearch.com/methodology/21355

The value-based healthcare system will help in achieving maximum value for the money spent on healthcare and thus, improve the outcomes through integrated care pathways, but at the same time will levy pricing pressure on the biopharmaceutical companies and may impact the investment in R&D of innovative medical treatment technologies. The global market for host cell contaminant testing market is expected to rise at a stable CAGR of 5.6% from 2017 to 2025. The market is expected to touch a US$ 354 Mn by the end of 2025.

Bio-Safety of Drugs to be Key Growth Driving Factor

Biopharmaceutical products manufactured from biological systems may be contaminated with host cell components. Host cell contaminants constitute major parts of process-related impurities and can severely affect drug safety. Even though low levels of most of the host cell contaminants may be insignificant, but due to patient safety host cell contaminants are reduced to low levels or eliminated to reduce adverse immune reactions.

Failure to identify host cell contaminants in early stages of manufacturing results in reduced drug efficacy or adverse reactions on patients. Biosafety of patient population is primary requisite, host cell contaminant testing is performed at each and every step of biopharmaceutical manufacturing to eliminate the risk of host cell contaminants.

However, the diversity of proteins which is within the host cell contaminants is expected to pose various challenges in the testing of contaminants in the coming years. Dearth of coverage for non-immune reactive host cell contaminants and lack of identification and specificity are expected further hinder the growth of the market in the long run.

Keeping A Tab On Key Players In The Host Cell Contaminant Testing Market? Go To “Purchase Now” To Decipher The Competitive Analysis In Our Host Cell Contaminant Testing Market Report! https://www.persistencemarketresearch.com/checkout/21355

North America Topping the Charts with High Adoption Rate

Region wise, the host cell contaminant testing market is sectioned into five key regions namely Latin America, North America, Asia Pacific (APAC), Europe, and the Middle East and Africa (MEA). The North America has turned into the lucrative market for host cell contaminant testing and is expected to rise as the quickest developing business sector because of activities like estimation of biotechnology programs that help the United Kingdom’s National Measurement System.

Asia Pacific area is relied upon to enlist a huge development over a figure period. Europe is additionally anticipated to enlist a noteworthy development in the host cell contaminant testing market over a conjecture period.

Based on product type, ELISA based assays segment is expected to occupy a huge share in the global cell contaminant testing market. On the basis of application, the market was led by product manufacturing.

About Us :-

Persistence Market Research is here to provide companies a one-stop solution with regards to bettering customer experience. It does engage in gathering appropriate feedback after getting through personalized customer interactions for adding value to customers’ experience by acting as the “missing” link between “customer relationships” and “business outcomes’. The best possible returns are assured therein.

Contact us:

Persistence Market Research
Address – 305 Broadway, 7th FloorNew York City,
NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – sales@persistencemarketresearch.com

Surgical Fluid Disposal Market 2022- Upcoming Trends, Growth Drivers and Challenges, Forecast to forecast year 2031

 Surgical Fluid Disposal Market 2022

Surgical fluids are generated in various procedures in the healthcare facility that are required to be disposed as they are collected. There are various devices available in the market for disposal of surgical fluids. To name a few, devices such as containers, tubing sets and waste bags are typically used for fluid disposal. These devices find use across various applications such as laparoscopy, gastroenterology, urology and gynecology and are used by hospitals, clinics as well as ambulatory surgical centers.

The growth of the global surgical fluid disposal market is influenced by factors such as increasing surgical procedures, technical advances in effective fluid disposal systems, convenience of disposal with the use of containers and tubing sets, growing minimally invasive surgeries and increasing funds from governments across regions for procedures related to endo-surgery. Fluids such as spinal fluids, blood, dialysis waste, saliva, lab specimen and cultures, amniotic fluids and other medications like chemotherapy drugs are typical examples of fluids that need to be disposed.

Planning Forward? Access Sample Of Surgical Fluid Disposal Market Report! https://www.persistencemarketresearch.com/samples/22300

Company Profiles

• B. Braun Melsungen AG
• Skyline Medical, Inc.
• Baxter International, Inc.
• Cardinal health, Inc.
• Hill Rom holdings, Inc.
• CR Bard, Inc.
• Medtronic Plc
• Olympus Corporation
• Stryker Corporation
• Smith & Nephew Plc

How About Revitalizing The Strategy-Oriented Funnel To Stay Ahead In The Surgical Fluid Disposal Market? https://www.persistencemarketresearch.com/methodology/22300 

A fact based research report on “Surgical fluid disposal Market: Global Industry Analysis (2012-2016) and Forecast (2017-2026)” by Persistence Market Research (PMR) reveals various aspects associated with the market’s growth. Several macroeconomic facets impacting the market along with supply chain analysis and vendor analysis have been included in this extensive research report.

This research can give the much needed value addition to the reader with which he/she can slate key strategies to gain strong market hold in the coming years. As per this research study, the global market for surgical fluid disposal is projected to grow at a value CAGR of 3.8% throughout the period of assessment (2017-2026) to reach a significant market valuation by the end of the forecast period.

4 Key Insights on Global Surgical fluid disposal Market

The global surgical fluid disposal market is segmented on the basis of product type, end user, application and region.

In the product type category, the containers segment is estimated to be the largest and highly attractive segment, largely contributing to the global market’s growth. This segment is projected to grow at a significant value CAGR during the forecast period. Also, the demand for tubing sets is expected to increase in the coming years, making tubing sets a high growth segment during the forecast period

In the application category, the demand for surgical fluid disposal is largely seen in laparoscopy. The laparoscopy application segment is expected to grow at a value CAGR of 4.4% throughout the period of forecast. Moreover, the urology segment is also expected to show significant adoption of devices for disposal of surgical fluids

Planning To Introduce An Offbeat Product/Technology In The Surgical Fluid Disposal Market? Go To “Purchase Now” To Have Our Surgical Fluid Disposal Market Report! https://www.persistencemarketresearch.com/checkout/22300

By region, North America is anticipated to the largest with a high market attractiveness. Moreover, the surgical fluid disposal market in North America is estimated to reach a high market valuation as compared to other regions and is expected to touch a billion dollar milestone by the end of the forecast period

With respect to end user, hospitals and ambulatory surgical centers have shown increased inclination towards adopting surgical fluid disposal. Hospitals segment is expected to portray high market share as well as favorable growth rate in the coming years. The adulatory surgical centers segment is projected to grow at a relatively high value CAGR throughout the assessment period.

About Us :-

Persistence Market Research is here to provide companies a one-stop solution with regards to bettering customer experience. It does engage in gathering appropriate feedback after getting through personalized customer interactions for adding value to customers’ experience by acting as the “missing” link between “customer relationships” and “business outcomes’. The best possible returns are assured therein.

Contact us:

Persistence Market Research
Address – 305 Broadway, 7th FloorNew York City,
NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – sales@persistencemarketresearch.com

Impact of COVID-19 on Global Male Hypogonadism Market: key Vendors, Trends, Analysis, Segmentation, Forecast to 2022-2031

 Male Hypogonadism Market 2022

According to Persistence Market Research’s new report, global male hypogonadism market is slated to exhibit a steady expansion throughout the forecast period (2017-2026). Revenues from the global market for male hypogonadism are estimated to exceed US$ 3,300 Mn by 2026-end.

Governments Taking Initiatives to Spread Awareness about Male Hypogonadism Therapeutics

Lack of sex hormones, usually referred to as male hypogonadism has resulted into many health risks that include osteoporosis, heart disease, and cardiovascular diseases on the back of thinning of bones. Global male hypogonadism market comprises several patented brands that currently have high market penetration. Proliferation in geriatric population in tandem with rising incidences related to rheumatoid arthritis and obesity have been primary factors affecting prevalence of male hypogonadism globally.

Strategizing The Moves For The Next Decade? See Through Sample Of Male Hypogonadism Market Report! https://www.persistencemarketresearch.com/samples/22303

Company Profiles

• Endo International Plc
• Eli Lilly and Company Ltd.
• AbbVie, Inc.
• Pfizer, Inc.
• Merck KGaA
• Allergan Plc
• Sun Pharmaceutical Industries Limited
• Ferring B.V.

Starting With The New Decade On A Diligent Note In The Male Hypogonadism Market? https://www.persistencemarketresearch.com/methodology/22303

Mounting incidences of testosterone deficiency in male population is a key factor that prevalence of male hypogonadism has surged worldwide. Several governments around the world have been taking initiatives to spread the awareness on hypogonadism treatment procedures, for example – testosterone replacement therapy (TST), in order to relieve the painful burden on patients and their families.

As low testosterone levels are increasingly associated with exacerbation of chronic conditions, it further results into disorders apropos to hypothalamic-pituitary-gonadal axis. Advent of TST has however enabled reduction in cases of male hypogonadism considerably. With growing awareness related to its treatment among patients, the market is likely to gain an uptick during the forecast period.

Rising availability of the selective androgen receptor modulators (SARMs) has further sustained the market expansion. The development and high availability of SARMs has led toward the provision of improved treatment procedure to patients having androgen deficiencies, thereby influencing the market growth.

How About Obtaining Insights About The Region To Enter Concerning The Male Hypogonadism Market? Press The “Purchase Now” Button To Have Our Male Hypogonadism Market Report! https://www.persistencemarketresearch.com/checkout/22303

North America will continue to Dominate Global Male Hypogonadism Market

North America will continue to dominate the global male hypogonadism market, with more than one-third revenue share during the forecast period. In addition, revenues from the male hypogonadism market in North America will exhibit the fastest expansion through 2026, as compared to those from all the other regional segments comprised in the report. Europe and Asia-Pacific excluding Japan (APEJ) are also expected to remain lucrative for the male hypogonadism market. The market in APEJ will ride on a slightly higher CAGR than that in Europe through 2026.

Topical gels are expected to remain the most lucrative among drugs available for treatment of male hypogonadism globally, with sales projected to register the fastest expansion through 2026. Injectables will also remain a major revenue contributor to the market. Sales of injectable and transdermal patches are poised to reflect an equal CAGR through 2026.

Testosterone Replacement Therapy to Remain Preferred among Patients

Based on therapy, testosterone replacement therapy is expected to remain preferred among patients with male hypogonadism worldwide. Roughly 66% revenue share of the market is expected to be held by revenues from testosterone replacement therapy by 2026-end. Revenues from gonadotropin replacement therapy will remain slightly more than half revenues gained from testosterone replacement therapy throughout the forecast period.

Klinefelter’s syndrome is expected to remain the most prevalent disease type observed in the male hypogonadism market, and revenues from treatment of this disease will exceed US$ 1,800 Mn by 2026-end. Kallmann Syndrome and Pituitary Adenomas among disease types will also account for major revenue shares of the market by 2026-end.

About Us :-

Persistence Market Research is here to provide companies a one-stop solution with regards to bettering customer experience. It does engage in gathering appropriate feedback after getting through personalized customer interactions for adding value to customers’ experience by acting as the “missing” link between “customer relationships” and “business outcomes’. The best possible returns are assured therein.

Contact us:

Persistence Market Research
Address – 305 Broadway, 7th FloorNew York City,
NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – sales@persistencemarketresearch.com

Pediatric Hearing Aids Market 2022 Industry Analysis, Size, Share, Strategies and Forecast to 2031

 Pediatric Hearing Aids Market 2022

Persistence Market Research (PMR) has recently published a new research report titled, “Pediatric Hearing Aids Market: Global Industry Analysis (2012 – 2016) and Forecast (2017 – 2025).” Hearing aids can help improve the hearing and speech of children with sensorineural hearing loss (hearing loss in the inner ear due to damaged hearing nerve).

Sensorineural hearing loss can be caused by noise, injury, infection, certain medications, birth defects, tumors, and problems related to blood circulation. According to the American Academy of Otolaryngology, over 3.0 million American children have hearing loss, and about 1.3 million of them younger than 3 years of age.

Want Insights To Pediatric Hearing Aids Market? Ask For Sample! https://www.persistencemarketresearch.com/samples/4734   

Company Profiles 

• William Demant Holding A/S
• Sonova
• Sivantos Pte. Ltd.
• GN Store Nord A/S
• Starkey Hearing Technologies, Inc.
• WIDEX USA, INC.
• Earlens Corporation
• Cochlear Limited
• IntriCon Corporation
• Amp

Planning To Conclude Your Strategy On A Decisive Note In The Pediatric Hearing Aids Market? Glance Through The “Methodology” Implied! https://www.persistencemarketresearch.com/methodology/4734  

More children would lose their hearing later in childhood. Moreover, around 90% of deaf children are born to parents with proper hearing ability. The global pediatric hearing aids market is projected to witness a CAGR of 5.3% from 2017 to 2025.

Growing disposable income of consumers living in middle-income regions is expected to boost the growth of hearing aids market in future. This in turn is expected to drive the demand for high quality hearing aids. In addition, adoption of hearing aids has been observed to be relatively less in developing countries. Several research activities are being undertaken by organizations for finding the cure for deafness among pediatrics employing stem cell technology.

Need for Advanced Diagnostics to Open a Plethora of Opportunities for Market Players

The introduction of advanced equipment for conducting diagnosis tests for the detection of loss of hearing among the pediatric population is expected to open up lucrative opportunities for the existing as well as new players in the global pediatric hearing aids market. The rising prevalence of hearing loss such as congenital hear loss problem and nerve deafness among children, is one of the primary aspects boosting the pediatric hearing aids market at present. The use of hearing aids has risen with the rise in the number of patients across the globe.

Thus, high demand for hearing aids will be the absolute opportunity for pediatric hearing aids vendors to capitalize on. The rise in health care awareness among parents in terms of children’s health issues is also expected to trigger the use the pediatric hearing aids in the near future.

 How About Knowing The Product/Technology Driving The Pediatric Hearing Aids Market Before Investing Therein? Click The “Purchase Now” Button Of Our Pediatric Hearing Aids Market Report! https://www.persistencemarketresearch.com/checkout/4734 

Most of the under developing countries evades the usage of hearing aids or any prosthetic device due to society insecurities. Moreover, today most of the hearing aids are based on digital technology which is easy to use and clearer to sound. Hence, the proliferating usage of digital hearing aids technology is likewise expected to play a pivotal role to lift the pediatric hearing aids market over the course of the forecast period.

Over the Ear to be the Most Preferred Product

In the course of the forecast period, over the ear products are going to be the most preferred product type for pediatrics. It is expected to touch a valuation of over US$1800 Mn by the end of 2025. Among the product types available under over the ear products, behind the ear will be the one witnessing the maximum sales. However, receiver in the canal is expected to witness the maximum growth over the forecast period.

About Us :-

Persistence Market Research is here to provide companies a one-stop solution with regards to bettering customer experience. It does engage in gathering appropriate feedback after getting through personalized customer interactions for adding value to customers’ experience by acting as the “missing” link between “customer relationships” and “business outcomes’. The best possible returns are assured therein.

Contact us:

Persistence Market Research
Address – 305 Broadway, 7th FloorNew York City,
NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – sales@persistencemarketresearch.com

 

Fluid Warmer Devices 2022 Global Market Share, Production Value, Cost Structure, Revenue and Future Demand to 2031

 Fluid Warmer Devices Market 2022

Fluid warmer devices, also called blood warmer devices are used to treat hypothermia. These devices are used in various healthcare facilities such as hospitals, ambulatory surgical centers and home care. The global fluid warmer devices market growth is largely influenced by the adoption rate of these devices across these facilities. The increasing prevalence of hypothermia is the main aspect driving the market’s growth. Likelihood of hypothermia in geriatric population and infants is high.

]The increasing geriatric population across the globe is expected to drive the use of fluid warmer devices, which in turn is anticipated to boost the growth of the global market for these devices. Also, the demand for fluid warmer devices is high in cold regions.

How About Looking Through The Sample Of Fluid Warmer Devices Market Report? https://www.persistencemarketresearch.com/samples/22222

Company Profiles

• 3M Company
• Emit Corporation
• General Electric Company
• Smiths Group Plc
• Stryker Corporation
• Geratherm Medical
• Belmont Instrument Corporation
• Biegler GmbH
• Barkey GmbH & Co. KG
• Stihler Electronic GmbH

How About Step-By-Step Insights To Fluid Warmer Devices Market? Look Through The “Methodology” Employed! https://www.persistencemarketresearch.com/methodology/22222

A comprehensive market research report titled “Fluid Warmer Devices: Global Industry Analysis (2012-2016) and Forecast (2017-2026)” by Persistence Market Research unveils several facets of the global market that have an impact on the global market’s growth.

The reader can gain directions to achieve stability in the changing market dynamics and can aim for future market expansions. According to the analysis include in this extensive research report, the global fluid warmer devices market is estimated to reach a significant by the end of the year of assessment and is projected to grow at a high value CAGR of 5.5% throughout the period of assessment (2017-2026).

Key Segmental Highlights of the Global Fluid Warmer Devices Market

The global fluid warmer devices market is segmented on the basis of product type, application, end user and region.

With respect to product type, the warming devices are extensively used for fluid or blood warming. The increasing adoption rate of warming devices can be attributed to better end results, due to which the warming devices segment is expected to be the largest with a high market value during the forecast period.

Moreover, this segment is projected to grow at the fastest rate throughout the period of forecast, 2017-2026. Disposable accessories segment is the second largest contributing significantly to the growth of the global fluid warmer devices market in the coming years.

Want To Keep A Tab On The Latest Findings In The Fluid Warmer Devices Market? Purchase Our Fluid Warmer Devices Market Report Now! https://www.persistencemarketresearch.com/checkout/22222

In the application category, the surgery segment is expected to grow at a significant pace during the assessment period. The use of fluid warmer devices during surgery is expected to grow in the coming years. The surgery application segment is estimated to reach a high market value of over US$ 55 Mn by 2026 end, thus dominating the global market. The adoption of fluid warmer devices for new born care and home care is also expected to grow in the years to follow.

By end user, the use of fluid warmer devices has been observed largely in hospitals and ambulatory surgical centers. Hospitals as an end user are highly lucrative for the growth of fluid warmer devices market across the globe.

The hospitals segment is expected to lead the global market and is expected to grow at a significant CAGR during the forecast period. In addition, the ambulatory surgical centers (ASCs) segment is projected to grow at the highest pace during the forecast period.

In the region category, North America and Europe, both are expected to highly contribute to the global market’s growth. Of these, North America is most attractive region for fluid warmer devices, followed by Europe.

On the other hand, the fluid warmer devices market in Asia Pacific excluding Japan (APEJ) region is projected to grow at a relatively higher pace in the coming years, followed by Europe. APEJ is expected to present potential growth opportunities for the adoption of fluid warmer devices.

About Us :-

Persistence Market Research is here to provide companies a one-stop solution with regards to bettering customer experience. It does engage in gathering appropriate feedback after getting through personalized customer interactions for adding value to customers’ experience by acting as the “missing” link between “customer relationships” and “business outcomes’. The best possible returns are assured therein.

Contact us:

Persistence Market Research
Address – 305 Broadway, 7th Floor, New York City,
NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – sales@persistencemarketresearch.com

Global Hair Transplant Services Market Trends, Drivers and Growth Projection Up to 2031

 Hair Transplant Services Market 2022

Technologies are driving the healthcare vertical through numerous innovations in the way diseases are diagnosed, prevented, and cured. With AI-driven technologies witnessing excessive incorporation in healthcare workflows, quality medical services are expected to get unleashed in higher proportion in the years to come. AI-based innovations help to foster mental health as well. Diagnostics are also expected to get better going with healthcare technology in the forecast period. This would be the way of operation of healthcare technology going forward.

People from every age group are facing hair fall related problems. This has created a demand for hair transplant and treatment across the globe which in turn is expected to spur the growth of the market for hair transplant services. People are more inclined towards hair transplant due to availability of new hair transplant services. The global market for hair transplant services includes three major types of procedures, i.e. Follicular Unit Strip Surgery (FUSS), Follicular Unit Extraction (FUE) and Scalp Reduction.

Get Free Sample Copy of this Report@ https://www.persistencemarketresearch.com/samples/11602

A new research report covers the complete scenario of the global hair transplant services market. Persistence Market Research in its new report titled ‘Hair Transplant Services Market: Global Industry Analysis (2012 – 2016) and Forecast (2017 – 2025)’ has covered a brief about the global hair transplant services market’s value, growth rate, trends, opportunities and drivers. According to the research study, the global hair transplant services market is expected to reach a value of over US$ 9,100 Mn by the end of 2025, growing at a CAGR of 6.7% during the forecast period.

Request for Methodology@ https://www.persistencemarketresearch.com/methodology/11602

Company Profiles:

• Bernstein Medical, P.C.
• Bosley Inc.
• Medicamat
• Hair Transplants of Florida
• The Ac?badem Hospitals Group
• Limmer Hair Transplant Center
• getFUE Hair Clinics Ltd
• Hair Transplant Center Turkey
• The Hairline Clinic
• Others.

 

The demand for hair transplant services is mainly driven by the increase in disposable income with the people and also an increase in the stress level among people which is resulting in their excessive hair loss. Increasing incidences of various dermatologic disorders and rise in number of reported side effects such as hair loss associated with chemotherapy in cancer patients are few factors expected to contribute significantly to growing demand for effective hair loss products. With growing demand, manufacturers are focusing on expanding their hair treatment and scalp treatment product lines in order to cater to the increasing needs of consumers for efficient hair loss treatments.

Global Hair Transplant Services Market: Segmental Insights

• Based on procedures, follicular unit strip surgery leads the market with a higher market share and growth rate. Follicular unit extraction segment stands at the second position leaving behind scalp reduction with the lowest market size during the forecast period.
• On the basis of end users, hospitals are expected to showcase maximum demand for hair transplant services. Hospitals segment is expected to reach a market value of over US$ 4,200 Mn by the end of 2025, growing at a value CAGR of 7.2% during the forecast period. Specialized clinics segment is also expected to be an attractive segment for hair transplant services.
• Among the regional segments, North America dominates the market with an estimated market value of over US$ 3,800 Mn by the end of 2025, growing at a CAGR 7.2% during the forecast period. APAC is also expected to be an attractive segment, growing at a significant CAGR during the forecast period.

Access Full Report@ https://www.persistencemarketresearch.com/checkout/11602

Key Questions Answered in This Report.

• What will the Market growth rate in Future?
• What are the key factors driving the global Market?
• Who are the key manufacturers in Market space?
• What are the opportunities and threats faced by the vendors in the global industry?
• What are sales, revenue, and price analysis by regions of industry?

About Us: Persistence Market Research

Contact Us:

Persistence Market Research
Address – 305 Broadway, 7th Floor, New York City, NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – sales@persistencemarketresearch.com

 

Advanced Wound Dressing Market 2022 Global Industry Sales, Supply, Consumption, Demand, Analysis and Forecasts to 2031

 Advanced Wound Dressing Market 2022

The Advanced Wound Dressing Market is destined to grow on an impertinent note, i.e. reaching US$ 8 Bn at a CAGR of 3.5% between 2022-2030. Personalization has taken over almost every sphere of the industry verticals, and healthcare is no exception. People have started looking at their healthcare picture such that they could actively take part in improving their physical and mental health on the daily basis. This personalization will be the face of the healthcare vertical in the forecast period.

Rising prevalence of chronic and surgical wounds across the world has led to a surge in the demand for advanced wound dressing procedures. Besides, the introduction of new advanced wound dressing products with better functionalities has also aided market growth. These is growing demand for advanced wound dressing products over traditional dressing products for the treatment of chronic wounds.

Get Free Sample Copy of this Report@ https://www.persistencemarketresearch.com/samples/31673

Increasing investments in new advanced wound dressing product development and growing efforts for their distribution by key stakeholders are major factors expected to surge the growth of the advanced wound dressing market. The global advanced wound dressing market is projected to exhibit a CAGR of 3.5% during the forecast period (2022–2030).

Company Profiles:

• Ethicon Inc. (Sub. of Johnson & Johnson)
• Smith & Nephew Plc
• ConvaTec Group Plc
• Coloplast A/S
• 3M Co
• BSN medical GmbH
• B.Braun Melsungen AG
• Mölnlycke Health Care
• Medline Industries Inc

Request for Methodology@ https://www.persistencemarketresearch.com/methodology/31673

Key Takeaways from Advanced Wound Dressing Market Study

• Based on product type, the foam dressing segment contributed the highest market share of around 27% to the global advanced wound dressing market in 2019, owing to their potential use in the treatment of chronic wounds.
• Growing prevalence of chronic diseases around the globe and high adoption of the advanced wound dressing for their treatment are expected to result in a notable market share of the chronic ulcers segment in the advanced wound dressing market.
• Institutional sales, including hospitals, clinics, ambulatory surgical centers, and long-term care centers, hold around three-fourth of value share in the advanced wound dressing market, due to their high service and increasing patient preference.
• North America holds the highest revenue share of 43%, and is expected to be the most lucrative region in the global advanced wound dressing market during the forecast period.
• Reluctant adoption and high cost of the products are factors expected to affect the growth of advance wound dressing, to a certain extent, across the globe.
• The COVID-19 pandemic will have a mixed effect on the advanced wound dressing market. While non-essential hospital procedures have been put off, those requires advanced wound care dressing will remain in place, thereby aiding market growth to a certain degree.

“Increasing preference of advanced wound dressing products for the treatment of chronic ulcers by clinicians, and continuous focus on the development of advanced wound dressing products with new functionalities by manufacturers, are projected to propel the growth of the global advanced wound dressing market over the coming years,” says a PMR analyst.

Launching New Products – Imperative Strategy for Market Players

Introduction of new innovative products as per patient needs is a major factor responsible for intense competition among market players in the global advanced wound dressing market. Several companies are focusing on launching versatile advanced wound dressing products to increase their product sales and expand their market share. For example, in February 2019, GEMCO Medical launched its GEMCORE360 brand of advanced wound dressing products, which includes foams, alginates, hydrocolloids, and thin-film dressings.

What Else is in the Report?

Persistence Market Research offers a unique perspective and actionable insights on the advanced wound dressing market in its latest study, presenting historical demand assessment of 2015–2019 and projections for 2020–2030, based on product type (hydrogels dressing, alginate dressings, semi-permeable film dressings, foam dressings, collagen dressings, hydrocolloid dressings, contact layers, super absorbent dressings, and hydrofibers), indication (chronic ulcers and non-healing surgical wounds), and distribution channel (institutional sales and retail sales), across seven key regions.

Access Full Report@ https://www.persistencemarketresearch.com/checkout/31673

About Us: Persistence Market Research

Contact Us:

Persistence Market Research
Address – 305 Broadway, 7th Floor, New York City, NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – sales@persistencemarketresearch.com

 

Endoscopes Market 2022 Global Industry Key Players, Share, Trend, Segmentation and Forecast to 2031

 Endoscopes Market 2022

The endoscopes market is estimated to reach US$ 12.5 Bn in the year 2021.The endoscopes market is slated to witness a CAGR of 6.5% between 2021 and 2031.

Endoscopes are gaining significant demand for arthroscopy, bronchoscopy, colonoscopy, and cystoscopy procedures. The shift toward minimally-invasive surgeries compared to open surgeries is likely to increase demand for endoscopes. Key stakeholders are introducing capsule endoscopes, robot-assisted endoscopes, and disposable endoscopes to overcome few drawbacks of conventional endoscopes.

Get Free Sample Copy@https://www.persistencemarketresearch.com/samples/31385

For instance, in July 2015, Medrobotics Corporation received FDA clearance for its Flex® Robotic System for sale in the United States. Also, international medical device manufactures are concentrating on entering the capsule and robot-assisted endoscopes market. For example, Medtronic now holds a leading market share in the capsule endoscopes market after its acquisition of Given Imaging Ltd.

The global endoscopes market was valued at US$ 11.8 Bn in 2019, and is expected to witness a CAGR of 6% during the forecast period (2020–2030).

Companies covered in Endoscopes Market Report

• Medtronic Plc.
• Olympus Corporation
• KARL STORZ SE & Co. KG
• Johnson & Johnson
• Fujifilm Holdings Corporation
• Richard Wolf GmbH
• Braun Melsungen Ag
• Stryker Corporation
• PENTAX Medical
• CONMED Corporation
• Boston Scientific Corporation
• Smith & Nephew PLC

Click Here for Methodology@https://www.persistencemarketresearch.com/methodology/31385

Key Takeaways of Endoscopes Market Study

• Flexible endoscopes occupied nearly 60% of value share in the endoscopes market in 2019, owing to increasing adoption over rigid endoscopes. Flexible endoscopes provide better safety, greater efficacy, and better accessibility to internal organs as compared to rigid endoscopes.
• Gastrointestinal (GI) endoscopy accounted for the highest value share in the global endoscopes market, on the back of increasing annual gastrointestinal and colonoscopy procedures.
• Bronchoscopy registered the highest growth rate owing to rising number of respiratory disorders and introduction of new endoscopy products for bronchoscopy.
• Reusable endoscopes accounted for more than three-fourth of the value share in global endoscopes market. Moreover, the disposable segment registered a higher growth rate as compared to the reusable segment, with the growing demand for procedure-specific endoscopes and benefits of sterilization cost reduction.
• Hospitals hold a major share in the global endoscopes market, owing to large-scale adoption of endoscopic surgeries and favorable reimbursement policies for patients who visit hospitals as compared to outpatient centers.
• North America holds a prominent revenue share in the global endoscopes market, as a higher number of endoscopic surgeries as performed each year in the country.

“Growing gastrointestinal and colorectal cancer cases and higher acceptance of minimally-invasive procedures are likely to pace up market growth. Demand for endoscopes will continue to pick pace with the introduction of new technologies for accurate visualization,” says a PMR analyst.

COVID-19 Impact on Endoscopes Market

The COVID-19 outbreak is asserting players in the endoscope market to restructure their working methods to suit drastic market changes. With governments implementing strict norms on physical movements and emphasis on social distancing, production is being significantly affected. Furthermore, shortage of manpower and travel restrictions are disrupting the supply chain, thereby affecting the overall workflow of the market. However, endoscopes, being an essential commodity in the healthcare industry, are likely to overcome these shortcomings caused by the pandemic.

On the back of persistent demand for endoscopes from healthcare institutions to detect cardiovascular diseases – which continue to cause a significant number of deaths all over the globe – the endoscopes market is likely to mitigate heavy damage. On this premise, Cook Medical, a prominent endoscopes manufacturer, stated that, it’s keeping production running with the available workforce and ensuring that the supply of essential devices is unhindered.

Product Portfolio Expansion and Distribution Partnerships – Key Strategies of Leading Manufacturers

Endoscope manufacturers are focusing on product portfolio expansion through partnerships and new product launches. For instance, in May 2018, FUJIFILM Holdings Corporation launched the EB-530P Slim Video Bronchoscope and Radial Probe EBUS System (PB2020-M).

Moreover, manufacturers are moving toward distribution agreements and partnerships to expand their presence in the global market. For example, in June 2018, CapsoVision announced a U.S. distribution partnership with Pentax Medical for capsule endoscopy solutions – CapsoCam Plus and CapsoCloud – across the country.

More Valuable Insights on Endoscopes Market

Persistence Market Research offers a unique perspective and actionable insights on endoscopes in its latest study, presenting historical demand assessment of 2015–2019 and projections for 2020–2030, on the basis of product (rigid endoscopes, flexible endoscopes, capsule endoscopes, and robot-assisted endoscopes), application (gastrointestinal (GI) endoscopy, laparoscopy, arthroscopy, obstetrics/gynecology endoscopy, urology endoscopy (cystoscopy), ENT endoscopy, bronchoscopy, mediastinoscopy, and others), usability (reusable and disposable), and end user (hospitals, ambulatory surgery centers, and specialty clinics), across seven major regions.

 Press The “Purchase Now” Button To Have Our Endoscopes Market Report@ https://www.persistencemarketresearch.com/checkout/31385

Endoscopes Market – Report Highlights

• A detailed overview of parent market of Endoscopes Market
• Changing Endoscopes Market dynamics in the industry
• In-depth segmentation of the Endoscopes Market
• Historical, current, and projected Endoscopes Market size regarding volume and value
• Recent industry trends and developments in Endoscopes Market
• Competitive landscape of the Endoscopes Market
• Strategies for key players and products offered
• Potential and niche segments, geographical regions exhibiting promising growth
• A neutral perspective on Endoscopes Market performance
• Must-have information for Endoscopes Market players to sustain and enhance their market footprint

About us: 

PersistenceMarketResearch is an esteemed company with a reputation of serving clients across domains of information technology (IT), healthcare, and chemicals. Our analysts undertake painstaking primary and secondary research to provide a seamless report with a 360 degree perspective. Data is compared against rep/uted organizations, trustworthy databases, and international surveys for producing impeccable reports backed with graphical and statistical information.

Contact us:

Persistence Market Research          
Address – 305 Broadway, 7th Floor, New York City,
NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – sales@persistencemarketresearch.com

Dengue Testing Market 2022 Global Trends, Market Share, Industry Size, Growth, Opportunities and Forecast to 2031

 Dengue Testing Market 2022

Government tendering and partnerships between diagnostic kit manufacturers are expected to provide long-term opportunities to the manufacturers in the dengue testing market. Governments in countries of Latin America and Asia Pacific are laying emphasis to eradicate diseases that have a higher infection rate by providing free diagnosis tests and medication to the underprivileged with the help of various government-funded programs.

However, in order to achieve these objectives, the local authorities need a constant supply of related diagnostic kits. Governments rely on tendering or partnerships with manufacturers for delivering the required kits. Such kind of mechanisms also provide a stable financial flow to the manufacturers for a particular period.

Planning Forward? Access Sample Of Dengue Testing Market Report! https://www.persistencemarketresearch.com/samples/22738

Company Profiles

• Abnova Corporation
• Roche Molecular Systems Inc.
• Abbott Laboratories
• InBios International, Inc.
• NovaTec Immundiagnostica GmbH
• Euroimmun AG (Sub. PerkinElmer)
• Quest Diagnostics
• Certaint Biotec SL
• OriGene Technologies
• Thermo Fisher Scientific Inc.

How About Revitalizing The Strategy-Oriented Funnel To Stay Ahead In The Dengue Testing Market? https://www.persistencemarketresearch.com/methodology/22738

These are some of the important findings of the latest report released by Persistence Market Research which is titled as ‘Dengue Testing Market: Global Industry Analysis 2012–2016 and Forecast 2017 – 2025’. Besides the qualitative analysis on the market dynamics operating in the global dengue testing market, the report also features a comprehensive quantitative assessment of the various segments and regions that are prominent in this market.

As per the numbers that are given in this report, the global dengue testing market was valued at US$ 451.6 Mn in 2017 and is forecasted to reach a valuation of US$ 739.4 Mn in 2025, displaying a CAGR of 6.4% during the period of assessment 2017-2025.

Global Dengue Testing Market: Dynamics

To control the spread of dengue fever, reduce the number of deaths and prevent its reoccurrence in the future, governments across the world have adopted various comprehensive dengue control policies that basically focus on prevention and cure.

The multi-pronged efforts for dengue control include provision of diagnosis and treatment facilities for dengue fever at all the health centers and adoption of preventive measures. Various countries have set up their own national programs such as the National Dengue Prevention and Control Program in countries such as Indonesia, Brazil, India and Philippines. The World Mosquito Program, formerly known as Eliminate Dengue is helping to protect the global population from mosquito-borne diseases. Such type of interventions are boosting the global dengue testing market all over the world.

Planning To Introduce An Offbeat Product/Technology In The Dengue Testing Market? Go To “Purchase Now” To Have Our Dengue Testing Market Report! https://www.persistencemarketresearch.com/checkout/22738

However, despite the high level of awareness for dengue prevention and cure, there are various challenges such as inadequate funding and resources and a lack of sound strategy to respond to the increasing problems related to dengue outbreaks in various regions of the world. Rapid urbanization, lack of sanitation, increase in international trade and mobility of population restraint the efforts to control dengue.

In addition, lack of well-organized dengue control programs in collaboration with different sectors and agencies also restraints the market growth of dengue testing.

Global Dengue Testing Market: Segmentation and Forecast

The global dengue testing market is segmented on the basis of product type, end-user and region.

• ELISA based tests segment accounted for 46.6% share in 2016 and is projected to account for 46.5% share by 2025 end in the global dengue testing market.
• The hospitals segment was valued at US$ 196.9 Mn in 2017 and is projected to reach a valuation of US$ 334.4 Mn in 2025, registering a CAGR of 6.8% during the period of assessment.
• Middle East and Africa dengue testing market was valued at US$ 139.7 Mn in 2017.

About Us :-

Persistence Market Research is here to provide companies a one-stop solution with regards to bettering customer experience. It does engage in gathering appropriate feedback after getting through personalized customer interactions for adding value to customers’ experience by acting as the “missing” link between “customer relationships” and “business outcomes’. The best possible returns are assured therein.

Contact us:

Persistence Market Research
Address – 305 Broadway, 7th FloorNew York City,
NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – sales@persistencemarketresearch.com

Global Pharmaceutical Excipients Market 2022 Industry Overview, Share, Trend, Segmentation and Forecast to 2031

 Pharmaceutical Excipients Market 2022

Microcrystalline cellulose (MCC) is one of the most widely used excipients in Europe and Asia Pacific. The prime reasons contributing to MCC’s popularity is its multi-functionality as a diluent used in direct compression and also that it is an anti-caking agent and an emulsifier. Furthermore, it fulfils all USP standards, which further drives its demand.

In addition, manufacture of oral liquid formulations is gaining popularity as a patient-centric drug delivery format, despite having shortcomings such as shorter shelf life and need for airtight packaging. In this context, oral liquid formulation administration is preferred for geriatric and paediatric patients and people suffering from chronic diseases such as cancer with reduced swallowing capacity.

Strategizing The Moves For The Next Decade? See Through Sample Of Pharmaceutical Excipients Market Report! https://www.persistencemarketresearch.com/samples/4421

Key Companies

• BASF SE,
• Evonik Industries AG,
• Innophos Holdings Inc.,
• The Lubrizol Corporation,
• The Dow Chemical Company,
• Wacker Chemie AG and
• Ashland Inc.

Starting With The New Decade On A Diligent Note In The Pharmaceutical Excipients Market? https://www.persistencemarketresearch.com/methodology/4421

Oral liquid formulations provide dosing flexibility, which is particularly suited to oral drugs that are dosed by patient weight or body surface area. However, excipient’s solubility and stability data is extremely important during excipient selection for oral liquid formulations.

These are some of the important findings of the latest report released by Persistence Market Research which is titled as ‘Pharmaceutical Excipients Market: Global Industry Analysis and Forecast 2017 – 2021’. Besides, this report also has a comprehensive section on the market dynamics affecting the global pharmaceutical excipients market and gives a clear picture regarding the factors that are affecting the market growth. As per the numbers provided in this report, the global pharmaceutical excipients market was valued at US$ 5,682.7 Mn in 2017 and is anticipated to reach a valuation of US$ 7,415.2 Mn in 2021 end, displaying a CAGR of 6.9% during the period of assessment 2017-2021.

Global Pharmaceutical Excipients Market: Dynamics

Increasing innovative collaborative research opportunities in pediatric formulations is being pushed through evolution of new regulations, additional funding opportunities, and increased public-private partnerships. This has been shifting focus to development of excipients used in both oral solid and liquid pediatric formulations, which are flexible, dispersible and multi-functional.

Furthermore, continued prioritization of unmet medical needs in pediatrics is expected to drive demand for these excipients and oral formulations in the forthcoming years.

It is also noted that stability testing of excipients is one the most important phases in determining the strength and efficacy of a drug. As more drug manufacturers rely on imports to fulfill requirements for excipients, the stability testing phase adds a layer of complexity to the already costly procedures. This results in uncertainty and lower revenue prospects for excipients manufacturers. These factors are likely to act a hurdle to the market growth of pharmaceutical excipients.

How About Obtaining Insights About The Region To Enter Concerning The Pharmaceutical Excipients Market? Press The “Purchase Now” Button To Have Our Pharmaceutical Excipients Market Report! https://www.persistencemarketresearch.com/checkout/4421

Global Pharmaceutical Excipients Market: Segmentation and Forecast

Global pharmaceutical excipients market is segmented on the basis of chemistry type, application type, functionality and by region.

• Plant-based chemistry type segment has been estimated to witness an increase in market value from US$ 1,650.4 Mn in 2017 to US$ 2,166.8 Mn by 2021.
• Oral applications segment is expected to witness a significant gain in market share during the forecast period, 2017-2021. Parenteral dosage forms are expected to witness lower uptake due to dearth of high purity certified excipients.
• Binders functionality segment is expected to witness increase in market value from US$ 2,494.2 Mn in 2017 to US$ 3,523.8 Mn by 2021, registering a robust CAGR during the period of assessment.
• North America market is expected to remain dominant in terms of production and sales of excipients, accounting for 36.5% of the total pharmaceuticals excipients market value by the end of 2021.

About Us :-

Persistence Market Research is here to provide companies a one-stop solution with regards to bettering customer experience. It does engage in gathering appropriate feedback after getting through personalized customer interactions for adding value to customers’ experience by acting as the “missing” link between “customer relationships” and “business outcomes’. The best possible returns are assured therein.

Contact us:

Persistence Market Research
Address – 305 Broadway, 7th FloorNew York City,
NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – sales@persistencemarketresearch.com

Canine Stem Cell Therapy Market 2022 Business Trends, Industry Profit Growth, COVID – 19 Outbreak, Historical Analysis, Top Key Players, Emerging Technologies and Global Segments

 Canine Stem Cell Therapy Market 2022

Persistence Market Research (PMR) has published a new research report on canine stem cell therapy. The report has been titled, “Canine Stem Cell Therapy Market: Global Industry Analysis 2016 and Forecast 2017–2026.” Veterinary research has been used in regenerative and adult stem cell therapy and has gained significant traction over the last decade.

Canine stem cell therapy products are identified to have gained prominence over the past five years, and according to the aforementioned research report, the market for canine stem cell therapy will expand at a moderate pace over the next few years.

How About Looking Through The Sample Of Canine Stem Cell Therapy Market Report? https://www.persistencemarketresearch.com/samples/15550  

Company Profiles

• VETSTEM BIOPHARMA
• Cell Therapy Sciences
• Regeneus Ltd.
• Aratana Therapeutics
• Medivet Biologics LLC
• Ocean
• Vetbiologics
• VetMatrix
• Magellan Stem Cells
• ANIMAL CELL THERAPIES, INC
• stemcellvet.co.uk

How About Step-By-Step Insights To Canine Stem Cell Therapy Market? Look Through The “Methodology” Employed! https://www.persistencemarketresearch.com/methodology/15550  

Though all animal stem cells are not approved by FDA, veterinary stem-cell manufacturers and university researchers have been adopting various strategies in order to meet regulatory approvals, and streamline and expedite the review-and-approval process. The vendors in the market are incessantly concentrating on research and development to come up with advanced therapy, in addition to acquiring patents.

In September 2017, VetStem Biopharma, Inc. received European patent granted to the University of Pittsburgh and VetStem received full license of the patent then. This patent will eventually provide the coverage for the ongoing commercial and product development programs of VetStem and might be also available for licensing to other companies who are rather interested in this field.

The other companies operating in the global market for canine stem cell therapy are VETherapy Corporation, Aratana Therapeutics, Inc., Regeneus Ltd, Magellan Stem Cells, Animal Cell Therapies, Inc., and Medrego, among others.

According to the Persistence Market Research report, the global canine stem cell therapy market is expected to witness a CAGR of 4.2% during the forecast period 2017-2026. In 2017, the market was valued at US$ 151.4 Mn and is expected to rise to a valuation of US$ 218.2 Mn by the end of 2026.

Burgeoning Prevalence of Chronic Diseases in Dogs to Benefit Market

Adipose Stem Cells (ASCs) are the most prevalent and in-demand adult stem cells owing to their safety profile, ease of harvest, and use and the ability to distinguish into multiple cell lineages. Most early clinical research is focused on adipose stem cells to treat various chronic diseases such as arthritis, tendonitis, lameness, and atopic dermatitis in dogs.

A large area of focus in veterinary medicine is treatment of osteoarthritis in dogs, which becomes more prevalent with age. Globally, more than 20% dogs are suffering from arthritis, which is a common form of canine joint and musculoskeletal disease. Out of those 20%, merely 5% seem to receive the treatment.

However, elbow dysplasia in canine registered a prevalence rate of 64%, converting it into an alarming disease condition to be treated on priority. Thereby, with the growing chronic disorders in canine, the demand for stem cell therapy is increasing at a significant pace.

Want To Keep A Tab On The Latest Findings In The Canine Stem Cell Therapy Market? Purchase Our Canine Stem Cell Therapy Market Report Now! https://www.persistencemarketresearch.com/checkout/15550  

Expensive Nature of Therapy to Obstruct Growth Trajectory

Expensive nature and limited access to canine stem cell therapy has demonstrated to be a chief hindrance forestalling its widespread adoption. The average tier II and tier III veterinary hospitals lack the facilities and expertise to perform stem cell procedures, which necessitates the referral to a specialty vet hospital with expertise veterinarians.

A trained veterinary physician charges high treatment cost associated with stem cell therapy for dogs. Generally, dog owners have pet insurance that typically covers maximum cost associated with steam cell therapy to treat the initial injury but for the succeeding measures in case of retreatment, the costs are not covered under the pet insurance. The stem cell therapy is thus cost-prohibitive for a large number of pet owners, which highlights a major restraint to the market growth. Stem cell therapy is still in its developmental stage and a positive growth outcome for the market cannot be confirmed yet.

About Us :-

Persistence Market Research is here to provide companies a one-stop solution with regards to bettering customer experience. It does engage in gathering appropriate feedback after getting through personalized customer interactions for adding value to customers’ experience by acting as the “missing” link between “customer relationships” and “business outcomes’. The best possible returns are assured therein.

Contact us:

Persistence Market Research
Address – 305 Broadway, 7th FloorNew York City,
NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – sales@persistencemarketresearch.com

Humanized Mice Model Market: Global Key Players, Trends, Share, Industry Size, Growth, Opportunities, Forecast To 2031

 Humanized Mice Model Market 2022

Persistence Market Research (PMR) has published a new research report on humanized mice model. The report has been titled, “Humanized Mice Model Market: Global Industry Key Analysis, Size, Share, Growth, Trends and Forecast 2017 – 2026.” In order to extemporize pre-clinical studies, humanized mice models surface as a better solution. With further development in genomic analysis, there is also a chance of refinement in the mouse models.

Humanized mice models have been in use mice for better understanding of the disease, in order to design effective therapies, create accurate models of drug metabolism and improve the understanding of mammalian and human genome function. Market players are incessantly competing for a significant value share and expansion of their global outreach by investing in technologies.

Get Going With Sample Of Humanized Mice Model Market Report! https://www.persistencemarketresearch.com/samples/22714

Company Profiles

• THE JACKSON LABORATORY
• Taconic Biosciences, Inc.
• Genoway S.A.
• Yecuris Corporation
• Charles River Laboratories, Inc.
• Crown Bioscience Inc.
• Ingenious Targeting Laboratory Inc.
• orizon Discovery Group plc
• HuMurine Technologies
• Trans Genic Inc., Ltd.

How About Re-Inventing The Methodical Wheel In The Humanized Mice Model Market? Switch Over To The “Methodology” Tab! https://www.persistencemarketresearch.com/methodology/22714  

With growing need to develop better varieties of humanized mice model and improve the quality and outcome of research studies, the demand for humanized mice models is increasing. However, various technical restrictions may pose as a challenge for the development of the market. Some of the leading companies operating in the market are The Jackson Laboratory, Crown Bioscience Inc. (JSR Life Science), Charles River Laboratories International, Inc., Taconic Biosciences, Inc., Ingenious Targeting Laboratory Inc., Trans Genic Inc., Ltd., GenOway, Creative Animodel, and Horizon Discovery Group plc.

According to the report, the global humanized mice model market is projected to exhibit a CAGR of 6.0% from 2017 to 2026. In 2017, the market was worth US$ 67.5 Mn and it has been estimated that it will touch a valuation of US$ 113.5 Mn by the end of 2026.

Technological Development to Trigger Demand for Humanized Mice Models

Novel technologies are being developed with each passing day, which permit robust genetic modification of mice, which accelerates the development of new immune deficient mice models for capitalizing on the discovery of novel approaches to enhance the engraftment of human cells or tissues.

Moreover, speedy technological advancements have been witnessed in the last 20 years, which comprise the genetic engineering of mouse genome such as the development of knock-out mouse, knock-in mouse as well as the transgenic mouse.

Keeping A Tab On Key Players In The Humanized Mice Model Market? Go To “Purchase Now” To Decipher The Competitive Analysis In Our Humanized Mice Model Market Report! https://www.persistencemarketresearch.com/checkout/22714

The aptitude to engraft mouse liver with human hepatocytes and mouse bone marrow with human hematopoietic stem cells is also foreseen to provide new opportunities, proliferating the market growth. These models also overcome the limitations of xenograft models as they elucidate disease etiology, tumor progression and metastasis.

Moreover, humanized mice strains provide better research models than working with mutant mouse protein. They are considered as more realistic models for tumor studies than the dish-grown cancer cells, and are also used for safety evaluation when neither normal mice nor rats can be used in particular biologics.

Availability of Substitutes to Hinder Market Growth

In addition to mice, other genetically modified species that can be used as models are being carefully measured for research purpose. Lately, knockout of CFTR gene has been stated in the pig as it is similar in size to humans and may be a superior model for the research on cardiovascular and metabolic diseases. Experimental advancements employing computer simulation, in silico, in vitro, and other non-animal approaches are also being taken up for the replacement of animal studies.

About Us :-

Persistence Market Research is here to provide companies a one-stop solution with regards to bettering customer experience. It does engage in gathering appropriate feedback after getting through personalized customer interactions for adding value to customers’ experience by acting as the “missing” link between “customer relationships” and “business outcomes’. The best possible returns are assured therein.

Contact us:

Persistence Market Research
Address – 305 Broadway, 7th FloorNew York City,
NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – sales@persistencemarketresearch.com

Global Rare Endocrine Disease Treatment Market 2022 to 2031 Available in New Research Report

 Rare Endocrine Disease Treatment Market 2022

The global rare endocrine disease treatment market will exhibit a moderate expansion in the period between 2017 and 2026, according to a new report of Persistence Market Research (PMR). Treatment of rare endocrine diseases across the globe are foreseen to close in on roughly US$ 12,000 Mn revenues by 2026-end.

Planning Forward? Access Sample Of Rare Endocrine Disease Treatment Market Report! https://www.persistencemarketresearch.com/samples/22579

Company Profiles

• Novartis
• Ipsen
• Pfizer, Inc.
• Teva
• EMD serono
• Novo Nordisk
• Eli Lilly
• Shire
• Amgen, Inc.
• Corcept Therapeutics
• Novelion Therapeutics

How About Revitalizing The Strategy-Oriented Funnel To Stay Ahead In The Rare Endocrine Disease Treatment Market? https://www.persistencemarketresearch.com/methodology/22579

endoVL Enabling Researchers to Collaborate on Rare Endocrine Disease Treatment Developments

A number of rare endocrine conditions that include disorders of sex development and adrenal tumors have made life of patients affected with these diseases miserable, thereby gaining attraction of researchers for developing treatment options. However researchers face challenges regarding collection of efficient patient data, which offer clinical trials with a powerful statistical support.

endoVL, by utilizing world-class research infrastructure of Australia, offers researchers with a secure online access to analytical tools & extensive data sets, so as to enable them to work together for developing effective treatment measures for rare endocrine diseases. With over 25 remarkable clinical trials on rare endocrine disease treatment drugs that are currently being run in endoVL, several research groups from around the world are working in collaboration to realize treatment options for these diseases.

North America to Remain Largest Market for Rare Endocrine Disease Treatment

Prevalence of Beckwith-Wiedemann Syndrome (BWS) is as significant as 1/10,000 live births. Rare endocrine tumors, such as neoplasia, have been associated with adults suffering from. Occurrence of BWS in the adult population has gained a slight uptick in North America, according to the NIH.

This has further triggered development and supply of treatment measures for this rare disease, underpinned by the region’s robust economic and resource vigour. PMR’s report estimates North America to remain the largest as well as the fastest-growing market for rare endocrine disease treatment.

Europe and Asia-Pacific excluding Japan (APEJ) are also expected to remain lucrative regions for growth of the rare endocrine disease treatment market. Revenues from the market in these two regions will register a moderate CAGR, and are collectively forecast to surpass those from North America by 2026-end.

Planning To Introduce An Offbeat Product/Technology In The Rare Endocrine Disease Treatment Market? Go To “Purchase Now” To Have Our Rare Endocrine Disease Treatment Market Report! https://www.persistencemarketresearch.com/checkout/22579

Acromegaly to Remain Most Prevalent Indication among Rare Endocrine Diseases

Acromegaly will continue to be the most prevalent indication among rare endocrine diseases, with revenues from treatment of this indication estimated to account for bulk share of the market during the period of forecast. Despite high rarity of acromegaly, progression of the disease has been insidious.

Researchers view earlier diagnosis and increased clinical vigilance to make real difference in lives of patients with acromegaly. Central diabetes insipidus will also prevail as a significant indication of rare endocrine disease, with revenues from treatment of this indication envisaged to surpass US$ 3,000 Mn by 2026-end.

Biologics will continue to be the preferred drug type for treatment of rare endocrine diseases. Although oral mode of administration of drugs related to rare endocrine diseases are witnessing a relatively faster penetration, revenues from their injectable counterparts are expected to remain larger throughout the forecast period. Based on distribution channel, hospital pharmacies will continue to lead the market, in terms of revenues.

About Us :-

Persistence Market Research is here to provide companies a one-stop solution with regards to bettering customer experience. It does engage in gathering appropriate feedback after getting through personalized customer interactions for adding value to customers’ experience by acting as the “missing” link between “customer relationships” and “business outcomes’. The best possible returns are assured therein.

Contact us:

Persistence Market Research
Address – 305 Broadway, 7th FloorNew York City,
NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – sales@persistencemarketresearch.com

 

Digital PCR Market by Size, Growth, Trends and Forecast – 2031

 Digital PCR Market 2022

The global digital PCR market is worth more than US$ 132 Mn at present. Demand for digital PCR is estimated to surge at a CAGR of 9.3% with an estimated value of US$ 347 Mn by 2031. User-friendly instruments of digital PCR, novel applications of digital PCR, and automation in advanced digital PCR instruments are some of the key trends in the market.

Get Sample Copy of this Report@ https://www.persistencemarketresearch.com/samples/20476

Digital PCR, or dPCR, is a new quantitative PCR method that enables ultrasensitive and reproducible detection as well as quantification of nucleic acid. It is an alternative method to conventional real-time qPCR, where the amplification reaction remains same but the method of quantifying the target sample differs.

Rising awareness about advanced molecular diagnostics is set to enhance the utilization of dPCR. Molecular diagnostics, specifically nucleic acid-based techniques for the detection of infectious diseases are rapidly growing approaches in clinical diagnostic laboratories. These techniques have been evolving since their development, including advances in digital PCR technologies that can now aid in the precise diagnosis of life-threatening diseases such as cancer and Ebola. There are several digital PCR-based diagnostic kits and assays for multiple diseases that have been introduced in molecular diagnosis over the previous decade.

Increasing global funding in research & development is adjacent to driving the demand of digital PCRs. Application of PCR-based techniques in drug discovery, genomics, and personalized medicine has augmented its penetration to reach the field of point-of-care molecular diagnostics. To address the global disease burden, there is a recent surge in the expenditure that contributes to the research and development of disease-related scientific studies. The trend is also encouraging molecular diagnostic manufacturers to invest more and support ongoing research in government and non-profit organizations.

Additionally, the National Institute of Health (NIH) has started the precision medicine initiative to address the issues and time associated with disease diagnosis and treatment. As opposed to the ‘one-size-fits-all’ treatment approach, precision medicine is an innovative approach that considers variety in people’s genes, environments, and lifestyles. Implementation of precision medicine has led to new discoveries and several FDA approvals for treatments pertaining to specific characteristics of an individual.

Company Profiles:

• Bio-Rad Laboratories, Inc.
• Agilent Technologies
• Thermo Fisher Scientific Inc.
• Fluidigm Corp
• Formulatrix, Inc
• JN Medsys
• ADJUST

 

Request for Methodology@ https://www.persistencemarketresearch.com/methodology/20476

Key Takeaways from Market Study

• By product, instruments are expected to hold over 70% market value share by the end of 2031, primarily because of the presence of key market players for production worldwide.
• Based on application, basic research is leading with nearly 35% market share, owing to extensive research opportunities in infection diagnosis and drug discovery.
• Research institutes dominated the end-user segment with a share of around 69.4% in 2020, due to increasing number of molecular biology companies focusing on infection diagnostics after the COVID-19 pandemic.
• By region, North America is slated to be the largest market with a value share of 35% by the end of the forecast period (2021 to 2031).

“Advancements in technology and application of digital PCR in drug discovery are anticipated to propel demand for as a measure for disease detection and prevention,” says an analyst of Persistence Market Research.

Market Competition

Acquisitions, mergers, expansions, and product launches are the key strategies adopted by manufacturers to increase their consumer base across geographies.

• On October 28, 2021, Bio-Rad Laboratories projected a growth rise in Q3 revenue after acquisition of dPCR maker, Dropworks.
• On September 20, 2021, Thermofisher launched the Applied Biosystems QuantStudio Absolute Q Digital PCR System, the first fully integrated digital PCR (dPCR) system designed to provide highly accurate and consistent results within 90 minutes.
• On January 14, 2019, Qiagen NV agreed to acquire certain molecular testing assets from Formulatrix Inc., including the CONSTELLATION® series of instruments.

What Does the Report Cover?

Persistence Market Research offers a unique perspective and actionable insights on the digital PCR market in its latest study, presenting historical demand assessment of 2016 – 2020 and projections for 2021 – 2031.

The research study is based on the product (instruments, consumables, and service), application (clinical diagnostics, basic research, applied research, and forensic testing), and end user (pharmaceutical companies, research institutes, forensic labs and agriculture companies), across seven key regions of the world.

Key geographies evaluated in this report are:
North America – U.S, Canada
Europe – France, Germany, Italy, Spain, and the UK, Eastern Europe, CIS
APAC – China, India, Japan, Australia, Others
Latin America – Argentina, Brazil, Others

Access Full Report@ https://www.persistencemarketresearch.com/checkout/20476

Key Questions Answered in This Report.

• What will the Market growth rate in Future?
• What are the key factors driving the global Market?
• Who are the key manufacturers in Market space?
• What are the opportunities and threats faced by the vendors in the global industry?
• What are sales, revenue, and price analysis by regions of industry?

About Us: Persistence Market Research

Contact Us:

Persistence Market Research          
Address – 305 Broadway, 7th Floor, New York City, NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – sales@persistencemarketresearch.com